Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near ...

The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,569.2 Million by 2030.

The American Heart Association says heart diseases are the leading cause of death in the US. Experts tell Digital Trends that ...

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

Severe Sleep Apnea), By treatment Type (Positive Airway Pressure (PAP) Therapy, Oral Appliance Therapy, Surgery), By Device Type (Continuous Positive Airway Pressure (CPAP) Devices, Auto-CPAP ...

Using a smartwatch can give you important health data you might not have access to otherwise, but you may be missing one huge aspect of the wearable.

Getting a good night’s sleep and waking up refreshed isn’t always easy.Whether it’s too much coffee, stress, a poor routine, ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and ...